Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Clinical guidance suggests starting with manufacturer recommendations as outlined in FDA labeling, then adjusting based on individual response
In the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study, patients with type 2 diabetes and high cardiovascular risk were randomized to receive a daily subcutaneous injection liraglutide or placebo
The best approach is balanced: keep the metabolic benefits, understand the retinal risk, and monitor the eye appropriately
[Accessed 20 January 2026] Acute Kidney Injury (2023) NHS [Accessed 20 January 2026] Acute Kidney Injury: What are the Risk Factors
About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world
US$ 21.33
US$ 22.66
US$ 28.28
